Applied Genetics News articles from August 1998

Applied Genetics News archives from August 1998

BIOPROCESSING: To Find Proteins, Try "Flash"
August 1, 1998... Aurora Biosciences (11149 N. Torrey Pines Road, La Jolla, CA 92037; Tel: 619/452-5000, Website: www.aurorabio.com) describes the specific covalent labeling of recombinant protein molecules inside live cells. An article written by B. Albert...

GENOMICS: Genome Therapeutics Prefers p53's Pathway
August 1, 1998... Genome Therapeutics (100 Beaver St., Waltham, MA 02154; Tel: 617/893- 5007, Fax: 617/893-8277) has acquired from Princeton University an exclusive license to proprietary genes regulated by the p53 tumor suppressor gene. The agreement will enable...

Testing Begins for Angiogenic Strategy
August 1, 1998... Cornell University Medical College (New York, NY; Tel: 212/746-2258) commenced Phase I/II trial to evaluate a new treatment for patients suffering from peripheral vascular disease (PVD) has begun at The New York Hospital-Cornell Medical Center....

Two Pursue Hepatitis Therapy
August 1, 1998... Schering-Plough Corp. (1 Giralda Farms, Madison, NJ 07940-1000; Tel: 201/822-7000, Fax: 201/822-7048 ) and Immune Response Corp. (5935 Darwin Court, Carlsbad, CA 92008; Tel: 619/431-7080, Fax: 619/431- 8636) are collaborating on research to come...

Gene Implicated in Psychiatric Disorders
August 1, 1998... Millennium Pharmaceuticals (640 Memorial Drive, Cambridge, MA 02139- 4815; Tel: 617/679-7000, Fax: 617/374-9379) and the Wyeth-Ayerst Research division of American Home Products (685 Third Ave., New York, NY 10017-4085; Tel: 212/878-5000; Also,...

CELL THERAPY: Tissue Engineering Approaches $435 M
August 1, 1998... Tissue engineering -- a field that didn't even exist as a discrete discipline 10 years ago and is just beginning to introduce commercial products -- attracted $435 million in global investment last year, 90% of it from private-sector investors....

Patents to Advanced Tissue Sciences
August 1, 1998... Advanced Tissue Sciences (10933 N. Torrey Pines Road, La Jolla, Ca 920387; Tel: 619/450-5730), the Massachusetts Institute of Technology (Cambridge, MA) and Children's Hospital (Boston, MA) have been the issued three U.S. patents covering the...

Hemosol Cultures Red Blood Cells
August 1, 1998... Hemosol (115 Skyway Ave., Etobicoke, ON M9W 4Z4, Canada; Tel: 416/798- 0700, Fax: 416/798-0151; Also, Toronto, Canada; Tel: 416-798-0700, Email: jhogan@equicomgroup.com, Website: www.hemosol.com) has been able to grow human hemoglobin-producing...

Procedure Repairs Damaged Brains
August 1, 1998... Physicians at the University of Pittsburgh Medical Center (Pittsburgh, PA; Tel: 412/624-2607, Fax, 412/624-3184, Email: kanny@a1.isd.upmc.edu or wardla@a1.isd.upmc.edu) performed the world's first cell transplant to reverse brain damage from...

Drug Expands Bone Marrow Population
August 1, 1998... Scientists have obtained large quantities of primary blood cells using "Argent," a proprietary technology of Ariad Pharmaceuticals (26 Landsdowne St., Cambridge, MA 02139; Tel: 617/494-0400). The technology is designed to allow control of...

ANTI-INFECTIVES: Killer T's Activated in Late-Stage AIDS
August 1, 1998... Findings by Charles Rinaldo, chairman of the Infectious Diseases and Microbiology Dept. at the University of Pittsburgh Medical Center (Pittsburgh, PA; Tel: 412/624-2607, Fax: 412/624-3184, Email: kempam@a1.isd.upmc.edu or wardla@a1.isd.upmc.edu,...

Ribi Adds Another Adjuvant
August 1, 1998... Ribi ImmunoChem Research (553 Old Corvallis Road, Hailton, MT 59840; Tel: 406/363-6214, Fax: 406/363-6129) has acquired rights to develop novel adjuvant technology that, the company says, has broad potential application in immunotherapy of cancer...

HORMONES, GROWTH FACTORS Recombinant Glucagon Challenges Extracts
August 1, 1998... Novo Nordisk (2880 Bagsvaerd, Denmark; Fax: 45/4449-0555; Also, Novo Nordisk Pharmaceuticals, 100 Overlook Center, Princeton, NJ 08540; Tel: 609/987-5800, Fax: 609/921-8082) has received FDA approval to market its recombinant glucagon in the...

Novo, Genentech Settle Dispute
August 1, 1998... Novo Nordisk (2880 Bagsvaerd, Denmark; Fax: 45/4449-0555, Website: www.novo.dk) and Genentech (1 DNA Way, S. San Francisco, CA 94080- 4990; Tel: 415/225-1000, Fax: 415/225-6000, Website: www.gene.com) reached an out-of-court settlement of...

Pfizer Completes NIF Phase I Trial
August 1, 1998... In an early-stage clinical trial conducted by Pfizer (235 East 42nd St., New York, NY 10017; Tel: 212/573-2323, Fax: 212/573-7851), NIF (neutrophil inhibitory factor) has been shown to reduce collateral brain injury following a stroke in relevant...

ANTIBODIES: MedImmune's Synagis Approved
August 1, 1998... MedImmune (35 W. Watkins Mill Road, Gaithersburg, MD 20878; Tel: 301/417-0770, Fax: 301/417-6289) has obtained FDA approval of its "Synagis" (palivizumab) for the preventive treatment of respiratory syncytial virus (RSV) in infants. The disease...

ENZYMES: Genzyme, Pharming Tackle Pompe's Disease
August 1, 1998... Genzyme General (1 Kendall Square, Cambridge, MA 02139-1562; Tel: 617/252-7500) and Pharming Group N.V. (Leiden, Netherlands) are forming a joint venture to develop and commercialize the enzyme human alpha-glucosidase as a treatment for Pompe's...

AGBIOTECH: Milestone in Monsanto Project
August 1, 1998... ArQule (200 Boston Ave., Medford, MA 02155; Fax: 781/395-6018, Website: www.arqule.com) has achieved a key milestone in a project for Monsanto (600 N. Lindbergh Ave., St. Louis, MO 63167; Fax: 314/694- 6572, Website: www.monsanto.com). This...

Brewery Gets into Bioengineering
August 1, 1998... Kirin Brewery Co. (10-1 Shinkawa 2-chome, Chuo-ku, Tokyo 104, Japan; Tel: 81/3/5540-3411, Fax: 81/3/5540-3547) has plans to begin test cultivation of a chrysanthemum resistant to multiple viruses through the use of genetic recombination...

Combining Resources Advances Plant Biotech
August 1, 1998... Mycogen (5501 Oberlin Drive, San Diego, CA 92121; Tel: 619/453-8030, Fax: 619/453-0142, Website: www.mycogen.com) and Rhone-Poulenc Agro (division of Rhone-Poulenc SA, 25, quai Paul Doumer, F92408 Courbevoie Cedex, France; Tel: 33147/681234, Fax:...

Alfalfa Crop Gets Boost from Companies
August 1, 1998... Mycogen (5501 Oberlin Drive, San Diego, CA 92121; Tel: 619/453-8030, Fax: 619/453-0142, Website: www.mycogen.com), New Mexico State University (Las Cruces, NM 88003-8001; Tel: 505/646-0111, Website: www.nmsu.edu), and Forage Genetics (N5292 S....

INDUSTRY NEWS: Dismal Showing for U.S. Biotech Stocks
August 1, 1998... Burrill & Co. (San Francisco, CA; Tel: 415/743-3163), a merchant bank and watcher of the biotechnology industry (and a part of Ernst & Young), says that despite a high media profile during the second quarter of 1998, Wall Street has shown little...

Mycogen Wins Bt Patent Suit
August 1, 1998... A Federal District Court jury ruled that a patent held by Monsanto (800 N. Lindbergh Blvd., St. Louis, MO 63167; Tel: 314/694-1000) that covers technology for modifying Bacillus thuringiensis (Bt) to make plants insect-resistant is invalid....

Genzyme Pulls Out of Research Products
August 1, 1998... Genzyme General (1 Kendall Square, Cambridge, MA 02139-1562; Tel: 617/252-7500) is selling the primary assets of its research products business to Techne Corp. (Minneapolis, MN) for an estimated $65 million before taxes. The purchase price...

Immunex, American Home Restructure Agreements
August 1, 1998... AGN Stock Watch (As of August 1, 1998, 2PM) This has been a generally positive month for biotechnology stocks, especially for the ones now relatively established through strong product portfolios on the market. Companies ...